Chris Degnan
Chief Financial Officer · UroGen Pharma Ltd.
IndividualSelling only
- 2024
- Oct 9, 2026
- 4
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Chris Degnan files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Mark Schoenberg - $4.48M in URGN purchases and sales in the last 12 months
- Jason Drew Smith - $212K in URGN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Chris Degnan?
Chris Degnan is a corporate insider, tracked as Chief Financial Officer of UroGen Pharma Ltd. (URGN). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Chris Degnan submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Chris Degnan been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($118K) across all tracked filings.
